http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103360327-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-36
filingDate 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103360327-B
titleOfInvention A kind of phenonaphthazine derivative and its preparation method and application
abstract The invention belongs to medicine and chemical field, disclose a kind of phenonaphthazine analog derivative and preparation method thereof and the purposes as cancer therapy drug.This phenonaphthazine derivative as shown in structural formula (I), wherein Rn 1 , Rn 2 for H, halogen ,-OCHn 3 or-NOn 2 ; And Rn 1 , Rn 2 =-O-CHn 2 -O-; N=1 or 2; R represents various aliphatic amide, comprises chain and ring-shaped fat amine.The present invention discloses the preparation method of this phenonaphthazine derivative and the purposes as cancer therapy drug thereof, this phenonaphthazine derivative has very strong restraining effect to topoisomerase I and topoisomerase II, to multiple JEG-3, there is significant restraining effect, have wide application space preparing on cancer therapy drug.
priorityDate 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006081331-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006081337-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449751050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419873785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5111791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559059
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450418934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117700725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3019885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424451722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID674
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420982033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424599094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453746828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559487
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449934660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562

Total number of triples: 54.